Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,119 public trials 2,034 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

A Study of JNJ-64264681 and JNJ-67856633 in Participants With Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia

NCT04657224

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +16 more
Locations
  • Stony Brook University Medical Center Stony Brook, New York, United States
  • Monash Medical Centre Clayton, Australia
  • Peter MacCallum Cancer Centre Melbourne, Australia
  • Linear Clinical Research Ltd Nedlands, Australia
View all 28 locations
View Trial Details
Completed

Trial of Mosunetuzumab (BTCT4465A) as Consolidation Therapy in Participants With Diffuse Large B-Cell Lymphoma Following First-Line Immunochemotherapy and as Monotherapy or in Combination With Polatuzumab Vedotin in Elderly/Unfit Participants With Previously Untreated Diffuse Large B-Cell Lymphoma

NCT03677154

Conditions
Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • University of Alabama at Birmingham School of Medicine Birmingham, Alabama, United States
  • University of California, Los Angeles (UCLA) - Hematology/Oncology Santa Monica Santa Monica, California, United States
  • Fort Wayne Medical Institute Fort Wayne, Indiana, United States
  • University of Maryland Medical Center Baltimore, Maryland, United States
View all 32 locations
View Trial Details
Completed

APG-2575 Single Agent or in Combination With Ibrutinib or Rituximab in Patients With Waldenström Macroglobulinemia

NCT04260217

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • City of Hope Duarte, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Mayo Clinic Jacksonville, Florida, United States
  • Weill Cornell Univ Hospitals New York, United States
View all 14 locations
View Trial Details
Completed

Dose Escalation Study of mRNA-2752 for Intratumoral Injection to Participants in Advanced Malignancies

NCT03739931

Conditions
Carcinoma, Carcinoma, Squamous Cell, Dose Escalation: Relapsed/Refractory Solid Tumor Malignancies or Lymphoma, +13 more
Locations
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • Providence St. John's Health Center Santa Monica, California, United States
  • University of Colorado Denver Aurora, Colorado, United States
  • Yale Cancer Center New Haven, Connecticut, United States
View all 24 locations
View Trial Details

Related conditions